Engineered microbial therapy for local metabolic modulation of the tumor microenvironment Oct. 14, 2021
Sulfopin, a new selective Pin1 inhibitor with in vivo anticancer activity in Myc-driven tumors Oct. 14, 2021
Vaxil reports data on P-Esbp-DOX in mouse model of aggressive liver metastasis of colorectal tumors Oct. 13, 2021
NCI grant supports development of ST-316 to treat Wnt/beta-catenin-dependent breast cancer Oct. 13, 2021